Respiratory Virus-related Emergency Department Visits and Hospitalizations Among Infants in New Zealand.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
entrez:
18
7
2020
pubmed:
18
7
2020
medline:
16
7
2021
Statut:
ppublish
Résumé
Estimates of the contribution of respiratory viruses to emergency department (ED) utilization remain limited. We conducted surveillance of infants with acute respiratory infection (ARI) associated ED visits, which then resulted in either hospital admission or discharge home. Seasonal rates of specific viruses stratified by age, ethnicity, and socioeconomic status were estimated for both visits discharged directly from ED and hospitalizations using rates of positivity for each virus. During the 2014-2016 winter seasons, 3585 (66%) of the 5412 ARI ED visits were discharged home directly and 1827 (34%) were admitted to hospital. Among visits tested for all respiratory viruses, 601/1111 (54.1%) of ED-only and 639/870 (73.4%) of the hospital-admission groups were positive for at least one respiratory virus. Overall, respiratory virus-associated ED visit rates were almost twice as high as hospitalizations. Respiratory syncytial virus was associated with the highest ED (34.4 per 1000) and hospitalization rates (24.6 per 1000) among infants. ED visit and hospitalization rates varied significantly by age and virus. Māori and Pacific children had significantly higher ED visit and hospitalization rates for all viruses compared with children of other ethnicities. Many infants with acute respiratory virus infections are managed in the ED rather than admitted to the hospital. Higher rates of ED-only versus admitted acute respiratory virus infections occur among infants living in lower socioeconomic households, older infants and infants of Māori or Pacific versus European ethnicity. Respiratory virus infections resulting in ED visits should be included in measurements of ARI disease burden.
Sections du résumé
BACKGROUND
Estimates of the contribution of respiratory viruses to emergency department (ED) utilization remain limited.
METHODS
We conducted surveillance of infants with acute respiratory infection (ARI) associated ED visits, which then resulted in either hospital admission or discharge home. Seasonal rates of specific viruses stratified by age, ethnicity, and socioeconomic status were estimated for both visits discharged directly from ED and hospitalizations using rates of positivity for each virus.
RESULTS
During the 2014-2016 winter seasons, 3585 (66%) of the 5412 ARI ED visits were discharged home directly and 1827 (34%) were admitted to hospital. Among visits tested for all respiratory viruses, 601/1111 (54.1%) of ED-only and 639/870 (73.4%) of the hospital-admission groups were positive for at least one respiratory virus. Overall, respiratory virus-associated ED visit rates were almost twice as high as hospitalizations. Respiratory syncytial virus was associated with the highest ED (34.4 per 1000) and hospitalization rates (24.6 per 1000) among infants. ED visit and hospitalization rates varied significantly by age and virus. Māori and Pacific children had significantly higher ED visit and hospitalization rates for all viruses compared with children of other ethnicities.
CONCLUSIONS
Many infants with acute respiratory virus infections are managed in the ED rather than admitted to the hospital. Higher rates of ED-only versus admitted acute respiratory virus infections occur among infants living in lower socioeconomic households, older infants and infants of Māori or Pacific versus European ethnicity. Respiratory virus infections resulting in ED visits should be included in measurements of ARI disease burden.
Identifiants
pubmed: 32675757
doi: 10.1097/INF.0000000000002681
pii: 00006454-202008000-00010
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e176-e182Subventions
Organisme : NCIRD CDC HHS
ID : U01 IP000480
Pays : United States
Références
Nair H, Simoes EA, Rudan I, et al.Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet. 2013;381:1380–1390.
Fell DB, Johnson J, Mor Z, et al.Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review. BMJ Open. 2017;7:e016526.
Hall CB, Weinberg GA, Blumkin AK, et al.Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132:e341–e348.
Lee WM, Kiesner C, Pappas T, et al.A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One. 2007;2:e966.
Calvo C, García-García ML, Sanchez-Dehesa R, et al.Eight year prospective study of adenoviruses infections in hospitalized children. Comparison with other respiratory viruses. PLoS One. 2015;10:e0132162.
von Linstow ML, Larsen HH, Eugen-Olsen J, et al.Human metapneumovirus and respiratory syncytial virus in hospitalized danish children with acute respiratory tract infection. Scand J Infect Dis. 2004;36:578–584.
Bourgeois FT, Valim C, Wei JC, et al.Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics. 2006;118:e1–e8.
Baker MG, Barnard LT, Kvalsvig A, et al.Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study. Lancet. 2012;379:1112–1119.
New Zealand Immunisation Advisory Centre. Eligibility criteria for FREE seasonal influenza vaccination 2020. Available at: https://www.influenza.org.nz/eligibility-criteria. Accessed February 25, 2020.
The New Zealand Formulary for Children. Palivizumab 2020. Available at: https://nzfchildren.org.nz/nzf_3478. Accessed February 25, 2020.
Jennings LC, Anderson TP, Werno AM, et al.Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections. Pediatr Infect Dis J. 2004;23:1003–1007.
Trenholme AA, Best EJ, Vogel AM, et al.Respiratory virus detection during hospitalisation for lower respiratory tract infection in children under 2 years in South Auckland, New Zealand. J Paediatr Child Health. 2017;53:551–555.
Huang QS, Baker M, McArthur C, et al.Implementing hospital-based surveillance for severe acute respiratory infections caused by influenza and other respiratory pathogens in New Zealand. Western Pac Surveill Response J. 2014;5:23–30.
Huang QS, Turner N, Baker MG, et al.Southern hemisphere influenza and vaccine effectiveness research and surveillance. Influenza Other Respir Viruses. 2015;9:179–190.
Lock A, Wright MAnalysis of presenting symptoms and diagnoses made at middlemore hospital: an audit carried out between monday 1 august and aunday 7 august 2016. N Z Med J. 2019;132:30–41.
Thornton V, Fogarty A, Jones P, et al.Why do patients self-present to middlemore hospital emergency department? N Z Med J. 2014;127:19–30.
Statistics New Zealand. Subnational population estimates, by age, sex, and ethnicity 2016. Available at: http://archive.stats.govt.nz/tools_and_services/nzdotstat/tables-by-subject/population-estimates-tables-16.aspx. Accessed May 30, 2016.
Institute of Environmental Science and Research Limited. Influenza surveillance in New Zealand: Annual Report 2014. Available at: https://surv.esr.cri.nz/PDF_surveillance/Virology/FluAnnRpt/InfluenzaAnn2014.pdf. Accessed December 04, 2017.
Institute of Environmental Science and Research Limited. Influenza surveillance in New Zealand: Annual Report 2015. Available at: https://surv.esr.cri.nz/PDF_surveillance/Virology/FluAnnRpt/InfluenzaAnn2015.pdf. Accessed December 04, 2017.
Institute of Environmental Science and Research Limited. Influenza surveillance in New Zealand: Annual Report 2016. Available at: https://surv.esr.cri.nz/PDF_surveillance/Virology/FluAnnRpt/InfluenzaAnn2016.pdf. Accessed December 04, 2017.
World Health Organisation (WHO). WHO surveillance case definitions for ILI and SARI 2014. Available at: https://www.who.int/influenza/surveillance_monitoring/ili_sari_surveillance_case_definition/en/. Accessed May 07, 2019.
Kim C, Ahmed JA, Eidex RB, et al.Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by real-time reverse transcription-PCR assays. PLoS One. 2011;6:e21610.
Shu B, Wu K-H, Emery S, et al.Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. J Clin Microbiol. 2011;49:2614–2619.
Szewczuk E, Thapa K, Anninos T, et al.Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infect Dis. 2010;10:113.
Atkinson J, Salmond C, Crampton PNZDep2013 Index of Deprivation. 2014.New Zealand: Ministry of Health;
Tobias M, Bhattacharya A, White PCross classification of the New Zealand population by ethnicity and deprivation: trends from 1996 to 2006. Aust N Z J Public Health. 2008;32:431–436.
Videla C, Carballal G, Misirlian A, et al.Acute lower respiratory infections due to respiratory syncytial virus and adenovirus among hospitalized children from Argentina. Clin Diagn Virol. 1998;10:17–23.
Prasad N, Trenholme AA, Huang QS, et alSHIVERS team. Interactive effects of age and respiratory virus on severe lower respiratory infection. Epidemiol Infect. 2018;146:1861–1869.
Grohskopf LA, Alyanak E, Broder KR, et al.Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2019-20 influenza season. MMWR Recomm Rep. 2019;68:1–21.
Mac S, Sumner A, Duchesne-Belanger S, et al.Cost-effectiveness of palivizumab for respiratory syncytial virus: a systematic review. Pediatrics. 2019;143:e20184064.
Karron RA, San Mateo J, Wanionek K, et al.Evaluation of a live attenuated human metapneumovirus vaccine in adults and children. J Pediatric Infect Dis Soc. 2018;7:86–89.
PATH. RSV Vaccine and mAb Snapshot 2019. Available at: https://path.azureedge.net/media/documents/RSV-snapshot-2019_08_28_High_Resolution_PDF.pdf. Accessed March 02, 2020.
New Zealand Ministry of Health. Annual Update of Key Results 2018/19: New Zealand Health Survey 2019. Available at: https://www.health.govt.nz/publication/annual-update-key-results-2018-19-new-zealand-health-survey. Accessed January 07, 2020.
Grant CC, Scragg R, Tan D, et al.Hospitalization for pneumonia in children in Auckland, New Zealand. J Paediatr Child Health. 1998;34:355–359.
Torzillo PJ, Chang ABAcute respiratory infections among Indigenous children. Med J Aust. 2014;200:559–560.
Iwane MK, Chaves SS, Szilagyi PG, et al.Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties--2002-2009. Am J Epidemiol 2013;177:656−665.
Karron RA, Singleton RJ, Bulkow L, et al.Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group. J Infect Dis. 1999;180:41–49.
Petousis-Harris H, et al.Pneumococcal conjugate vaccines turning the tide on inequity: a retrospective cohort study of New Zealand children born 2006-2015. Clin Infect Dis 2019;68:818–826.
Moore HC, Lehmann D, de Klerk N, et al.Reduction in disparity for pneumonia hospitalisations between Australian Indigenous and non-Indigenous children. J Epidemiol Community Health. 2012;66:489–494.
Prasad N, Newbern EC, Trenholme AA, et al.Respiratory syncytial virus hospitalisations among young children: a data linkage study. Epidemiol Infect. 2019;147:e246.